Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Ruud Dings

Concepts (317)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Angiogenesis Inhibitors
25
2022
184
3.890
Why?
Proteins
17
2010
354
2.320
Why?
Neovascularization, Pathologic
17
2022
158
2.310
Why?
Calixarenes
7
2017
9
1.860
Why?
Melanoma, Experimental
6
2021
34
1.770
Why?
Galectin 1
8
2024
20
1.740
Why?
Antineoplastic Agents
14
2024
1219
1.490
Why?
Peptides
20
2017
236
1.300
Why?
Mice
47
2024
5943
1.220
Why?
Neoplasms
14
2024
1301
1.150
Why?
Animals
53
2024
13464
1.000
Why?
Endothelial Cells
10
2022
283
0.990
Why?
Lung Neoplasms
5
2024
633
0.980
Why?
Gold
7
2023
85
0.860
Why?
Ovarian Neoplasms
8
2008
460
0.840
Why?
Oxygen
6
2020
334
0.810
Why?
Cell Line, Tumor
18
2024
1435
0.770
Why?
Carcinoma, Non-Small-Cell Lung
1
2024
169
0.740
Why?
Carcinoma, Squamous Cell
4
2019
330
0.720
Why?
Proto-Oncogene Proteins c-met
1
2021
19
0.700
Why?
Peptide Fragments
5
2013
210
0.690
Why?
Mammary Neoplasms, Experimental
6
2015
122
0.680
Why?
Radiation-Sensitizing Agents
4
2023
52
0.680
Why?
Head and Neck Neoplasms
3
2019
287
0.650
Why?
Carcinoma, Lewis Lung
1
2019
10
0.640
Why?
Molecular Targeted Therapy
2
2018
133
0.620
Why?
Preservation, Biological
1
2018
9
0.610
Why?
Lymphocytes, Tumor-Infiltrating
1
2019
78
0.610
Why?
Protein Kinase Inhibitors
1
2021
228
0.600
Why?
Radiation Tolerance
5
2020
84
0.600
Why?
CD8-Positive T-Lymphocytes
1
2019
131
0.600
Why?
Anti-Bacterial Agents
4
2019
802
0.590
Why?
Galectins
1
2018
7
0.580
Why?
Metal Nanoparticles
4
2023
66
0.550
Why?
Hyperthermia, Induced
3
2019
114
0.530
Why?
Bacteria
1
2018
220
0.530
Why?
Mice, Nude
12
2019
235
0.520
Why?
Radiotherapy
5
2021
129
0.510
Why?
Xenograft Model Antitumor Assays
11
2020
222
0.490
Why?
Pseudomonas aeruginosa
2
2013
77
0.460
Why?
Combined Modality Therapy
11
2020
636
0.420
Why?
Benzofurans
2
2012
18
0.410
Why?
Cytotoxins
1
2013
15
0.410
Why?
Cell Proliferation
10
2024
1027
0.400
Why?
Drug Design
4
2014
121
0.390
Why?
Oxidation-Reduction
3
2024
327
0.390
Why?
Pseudomonas Infections
1
2013
54
0.390
Why?
Endothelium, Vascular
8
2010
258
0.390
Why?
Carbohydrate Metabolism
1
2012
25
0.390
Why?
Humans
44
2024
52513
0.380
Why?
Nanostructures
3
2023
42
0.380
Why?
Neoplasms, Experimental
4
2020
112
0.380
Why?
Benzeneacetamides
2
2024
12
0.380
Why?
Glutaminase
2
2024
18
0.370
Why?
Bacteremia
1
2013
90
0.370
Why?
Sesquiterpenes
3
2010
92
0.360
Why?
Angiostatic Proteins
1
2011
1
0.350
Why?
Immunity, Cellular
1
2011
64
0.340
Why?
Cell Survival
8
2024
602
0.340
Why?
Molecular Mimicry
2
2007
36
0.340
Why?
Dendritic Cells
3
2021
136
0.330
Why?
Endothelium
4
2022
38
0.330
Why?
Carboplatin
3
2024
57
0.320
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2008
1030
0.320
Why?
Tumor Necrosis Factor-alpha
4
2019
395
0.310
Why?
Immunotherapy, Adoptive
1
2011
167
0.300
Why?
Cells, Cultured
8
2013
1587
0.300
Why?
Apoptosis
7
2024
1120
0.300
Why?
Vascular Endothelial Growth Factor A
7
2022
187
0.300
Why?
Intercellular Adhesion Molecule-1
5
2022
59
0.300
Why?
T-Lymphocytes
1
2011
327
0.300
Why?
Structure-Activity Relationship
6
2012
405
0.290
Why?
Polyethylene Glycols
3
2021
90
0.290
Why?
Mice, Inbred C57BL
8
2021
1897
0.290
Why?
Phototherapy
2
2019
26
0.290
Why?
Tumor Cells, Cultured
6
2019
448
0.280
Why?
Amino Acid Sequence
5
2012
572
0.280
Why?
Female
24
2020
28219
0.270
Why?
Drug Resistance, Neoplasm
2
2024
327
0.270
Why?
Magnetic Resonance Spectroscopy
5
2012
253
0.260
Why?
Blood Vessels
4
2015
72
0.250
Why?
Antibodies, Monoclonal
2
2007
478
0.250
Why?
Molecular Sequence Data
5
2012
770
0.240
Why?
Disease Models, Animal
7
2020
1481
0.240
Why?
Nanoparticles
2
2017
127
0.230
Why?
Cell Division
7
2010
288
0.220
Why?
Bystander Effect
1
2024
25
0.220
Why?
Cysteine
1
2024
50
0.220
Why?
Buthionine Sulfoximine
1
2024
13
0.220
Why?
Human Umbilical Vein Endothelial Cells
3
2014
102
0.220
Why?
Nanotubes
2
2021
17
0.220
Why?
Models, Molecular
4
2024
352
0.210
Why?
Thiadiazoles
2
2024
18
0.210
Why?
Flow Cytometry
2
2017
400
0.210
Why?
Cisplatin
1
2024
285
0.190
Why?
Alanine
3
2012
43
0.190
Why?
Protein Binding
3
2012
671
0.180
Why?
Carcinoma, Renal Cell
1
2022
111
0.180
Why?
Binding Sites
2
2012
377
0.180
Why?
Optical Imaging
2
2020
25
0.180
Why?
Silver
2
2021
47
0.180
Why?
Polyurethanes
1
2021
10
0.180
Why?
Kidney Neoplasms
1
2022
181
0.180
Why?
Radiation
1
2020
14
0.170
Why?
Materials Testing
1
2021
55
0.170
Why?
Forkhead Transcription Factors
1
2021
121
0.170
Why?
Spectrum Analysis
1
2020
54
0.170
Why?
Biocompatible Materials
1
2021
65
0.170
Why?
Mice, Inbred BALB C
5
2020
310
0.160
Why?
CD4-Positive T-Lymphocytes
1
2021
165
0.160
Why?
Neoplasm Transplantation
5
2007
86
0.160
Why?
Mice, Knockout
3
2012
910
0.160
Why?
Disease Progression
3
2019
872
0.160
Why?
Oxygen Consumption
1
2020
200
0.160
Why?
Lactose
2
2024
8
0.160
Why?
Spectrum Analysis, Raman
1
2019
42
0.150
Why?
Immunotherapy
1
2020
244
0.150
Why?
Specimen Handling
1
2018
56
0.150
Why?
Biological Assay
1
2018
47
0.150
Why?
Drug Delivery Systems
2
2019
147
0.150
Why?
Time Factors
6
2017
2997
0.150
Why?
Indazoles
1
2018
47
0.140
Why?
Carbohydrates
1
2018
41
0.140
Why?
Feces
1
2018
154
0.140
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2018
62
0.140
Why?
Temperature
1
2018
165
0.140
Why?
Cell Hypoxia
4
2015
83
0.140
Why?
Histocompatibility Antigens Class II
1
2017
34
0.140
Why?
Neoplastic Cells, Circulating
1
2017
34
0.140
Why?
Tumor Microenvironment
1
2019
254
0.130
Why?
Drug Therapy, Combination
1
2018
400
0.130
Why?
Male
9
2019
26816
0.130
Why?
Epithelial Cells
1
2018
214
0.130
Why?
Cell Line
4
2017
1030
0.130
Why?
Lipopolysaccharides
2
2008
205
0.130
Why?
Umbilical Veins
4
2010
21
0.130
Why?
Enzyme Inhibitors
1
2018
371
0.120
Why?
Molecular Imaging
1
2015
28
0.120
Why?
Leukocytes
3
2006
60
0.120
Why?
Azides
1
2014
9
0.110
Why?
Fluorine Radioisotopes
1
2014
25
0.110
Why?
Tumor Burden
2
2013
136
0.110
Why?
Cell Transformation, Neoplastic
2
2007
184
0.110
Why?
Immunohistochemistry
5
2020
981
0.110
Why?
Interleukin-2
2
2021
69
0.110
Why?
Drug Synergism
2
2005
148
0.110
Why?
Cell Adhesion
3
2006
164
0.110
Why?
Piperacillin
1
2013
24
0.100
Why?
Peptidomimetics
1
2012
2
0.100
Why?
Penicillanic Acid
1
2013
21
0.100
Why?
Agglutination Tests
1
2012
5
0.100
Why?
Allosteric Regulation
1
2012
16
0.100
Why?
Inflammation Mediators
1
2013
116
0.100
Why?
Cell Cycle
1
2013
240
0.090
Why?
Antimicrobial Cationic Peptides
2
2008
30
0.090
Why?
Neoplastic Stem Cells
1
2012
93
0.090
Why?
Up-Regulation
2
2011
462
0.090
Why?
Partial Pressure
1
2011
14
0.090
Why?
Metformin
1
2012
81
0.090
Why?
Glutamine
2
2024
176
0.090
Why?
Adjuvants, Immunologic
1
2011
52
0.090
Why?
Fibroblasts
1
2013
359
0.090
Why?
Chemotherapy, Adjuvant
1
2011
124
0.090
Why?
Spiro Compounds
1
2010
8
0.080
Why?
Cell Movement
4
2006
275
0.080
Why?
Cytokines
1
2013
624
0.080
Why?
Lignans
1
2008
7
0.070
Why?
Salmonella typhimurium
1
2008
42
0.070
Why?
Klebsiella pneumoniae
1
2008
20
0.070
Why?
Amino Acid Substitution
1
2008
80
0.070
Why?
Furans
1
2008
30
0.070
Why?
Surface Properties
1
2007
62
0.070
Why?
Escherichia coli
1
2008
186
0.070
Why?
Angiostatins
2
2006
2
0.070
Why?
Endotoxins
1
2006
22
0.070
Why?
Vascular Neoplasms
1
2007
17
0.070
Why?
Concept Formation
1
2006
12
0.070
Why?
Gram-Negative Bacteria
1
2006
34
0.060
Why?
Protein Structure, Secondary
2
2003
71
0.060
Why?
Interleukin-8
1
2006
86
0.060
Why?
Genes, Synthetic
1
2005
1
0.060
Why?
Protein Engineering
1
2005
18
0.060
Why?
Antibodies, Monoclonal, Humanized
1
2007
235
0.060
Why?
Cloning, Molecular
1
2005
181
0.060
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2006
149
0.060
Why?
Angiogenic Proteins
1
2004
5
0.060
Why?
Colonic Neoplasms
1
2006
163
0.060
Why?
Dietary Supplements
1
2008
465
0.060
Why?
Protein Unfolding
1
2024
7
0.060
Why?
Histones
1
2006
316
0.060
Why?
Feasibility Studies
1
2006
403
0.060
Why?
Disulfides
1
2024
17
0.060
Why?
Diphtheria Toxin
1
2004
5
0.060
Why?
Mutagenesis, Site-Directed
1
2024
97
0.060
Why?
Protein Folding
1
2024
61
0.050
Why?
Mammary Neoplasms, Animal
1
2004
33
0.050
Why?
Osmosis
1
2003
5
0.050
Why?
Infusion Pumps
1
2003
12
0.050
Why?
Circular Dichroism
1
2003
42
0.050
Why?
Plasminogen
1
2003
3
0.050
Why?
Dose-Response Relationship, Drug
2
2004
1372
0.050
Why?
Serum Albumin
1
2003
58
0.050
Why?
Extracellular Matrix
1
2003
112
0.050
Why?
Immune Tolerance
1
2022
91
0.050
Why?
Gene Expression Regulation, Neoplastic
4
2008
856
0.050
Why?
Reactive Oxygen Species
1
2024
422
0.050
Why?
Endostatins
3
2007
4
0.050
Why?
Neoplasm Invasiveness
1
2022
278
0.050
Why?
Immune System
1
2021
41
0.050
Why?
Immunity
1
2021
40
0.040
Why?
Melanoma
1
2004
279
0.040
Why?
Ethers
1
2021
8
0.040
Why?
Regenerative Medicine
1
2021
12
0.040
Why?
Tissue Scaffolds
1
2021
40
0.040
Why?
Angiogenesis Inducing Agents
1
2000
7
0.040
Why?
Dose-Response Relationship, Radiation
1
2020
183
0.040
Why?
Tissue Engineering
1
2021
74
0.040
Why?
Bone Marrow Cells
1
2021
190
0.040
Why?
Adenocarcinoma
1
2004
404
0.040
Why?
Mice, Inbred C3H
2
2012
81
0.040
Why?
Gene Expression Profiling
1
2004
1108
0.040
Why?
Skin Neoplasms
1
2004
500
0.040
Why?
Flavin-Adenine Dinucleotide
1
2018
4
0.040
Why?
NAD
1
2018
45
0.040
Why?
Inflammation
1
2022
644
0.040
Why?
Microcirculation
2
2010
63
0.040
Why?
Guidelines as Topic
1
2018
110
0.040
Why?
Microscopy, Fluorescence
1
2018
147
0.030
Why?
Glutathione
1
2019
305
0.030
Why?
Phagocytosis
1
2017
54
0.030
Why?
Glycolysis
1
2017
73
0.030
Why?
Transplantation, Heterologous
2
2008
78
0.030
Why?
Clonal Anergy
2
2006
13
0.030
Why?
Extracellular Fluid
1
2015
14
0.030
Why?
Nitroimidazoles
1
2015
16
0.030
Why?
Microbubbles
1
2015
26
0.030
Why?
Cell Count
1
2015
144
0.030
Why?
Stromal Cells
1
2015
77
0.030
Why?
Pressure
1
2015
103
0.030
Why?
Down-Regulation
2
2006
344
0.030
Why?
Paclitaxel
2
2006
91
0.030
Why?
Drug Evaluation, Preclinical
1
2015
142
0.030
Why?
Cycloaddition Reaction
1
2014
1
0.030
Why?
Radiochemistry
1
2014
2
0.030
Why?
Click Chemistry
1
2014
3
0.030
Why?
Random Allocation
1
2015
285
0.030
Why?
Radiotherapy Dosage
1
2015
253
0.030
Why?
Recombinant Proteins
2
2006
495
0.030
Why?
Imaging, Three-Dimensional
1
2015
151
0.030
Why?
Cell Differentiation
1
2017
673
0.030
Why?
Contrast Media
1
2015
173
0.030
Why?
Molecular Structure
1
2014
315
0.030
Why?
Ultrasonography
1
2015
424
0.030
Why?
Chromatography, High Pressure Liquid
1
2014
335
0.030
Why?
Ribosomal Protein S6 Kinases
1
2012
8
0.020
Why?
Adenylate Kinase
1
2012
10
0.020
Why?
TOR Serine-Threonine Kinases
1
2012
82
0.020
Why?
Rats
2
2008
3181
0.020
Why?
Radiometry
1
2012
127
0.020
Why?
4-Butyrolactone
1
2008
5
0.020
Why?
Butylene Glycols
1
2008
14
0.020
Why?
Phytoestrogens
1
2008
23
0.020
Why?
9,10-Dimethyl-1,2-benzanthracene
1
2008
50
0.020
Why?
Ovariectomy
1
2008
113
0.020
Why?
Receptors, Progesterone
1
2008
66
0.020
Why?
Estrogen Receptor beta
1
2008
54
0.020
Why?
Estrogen Receptor alpha
1
2008
85
0.020
Why?
Carcinogens
1
2008
193
0.020
Why?
Cell Growth Processes
1
2007
24
0.020
Why?
Horseshoe Crabs
1
2006
3
0.020
Why?
Blood Bactericidal Activity
1
2006
4
0.020
Why?
Lipid A
1
2006
4
0.020
Why?
Polymyxin B
1
2006
4
0.020
Why?
Neutralization Tests
1
2006
26
0.020
Why?
Cytidine
1
2006
5
0.020
Why?
Pyrroles
1
2007
72
0.020
Why?
DNA Modification Methylases
1
2006
28
0.020
Why?
Endotoxemia
1
2006
35
0.020
Why?
Acetylation
1
2006
96
0.020
Why?
Methylation
1
2006
126
0.020
Why?
Vimentin
1
2006
32
0.020
Why?
Chick Embryo
1
2006
81
0.020
Why?
Blood Proteins
1
2006
84
0.020
Why?
Gene Silencing
1
2006
120
0.020
Why?
Nucleic Acid Hybridization
1
2006
55
0.020
Why?
Cyclohexanes
1
2006
4
0.020
Why?
Transfection
1
2007
368
0.020
Why?
Zebrafish
1
2006
60
0.020
Why?
Histone Deacetylase Inhibitors
1
2006
58
0.020
Why?
Histone Deacetylases
1
2006
51
0.020
Why?
Vascular Cell Adhesion Molecule-1
1
2006
38
0.020
Why?
Pichia
1
2005
8
0.020
Why?
Gene Transfer Techniques
1
2005
42
0.010
Why?
Cyclophosphamide
1
2006
172
0.010
Why?
Neovascularization, Physiologic
1
2005
87
0.010
Why?
Sequence Homology, Nucleic Acid
1
2004
48
0.010
Why?
Membrane Proteins
1
2006
336
0.010
Why?
Indoles
1
2007
276
0.010
Why?
Treatment Outcome
1
2014
5480
0.010
Why?
Necrosis
1
2004
170
0.010
Why?
Skin
1
2007
418
0.010
Why?
Antibodies
1
2004
150
0.010
Why?
In Situ Nick-End Labeling
1
2003
54
0.010
Why?
Base Sequence
1
2004
634
0.010
Why?
Sequence Homology, Amino Acid
1
2003
137
0.010
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2004
582
0.010
Why?
Epigenesis, Genetic
1
2006
403
0.010
Why?
Mice, Transgenic
1
2004
563
0.010
Why?
RNA, Messenger
1
2004
1139
0.010
Why?
Endothelial Growth Factors
1
2000
11
0.010
Why?
Vascular Endothelial Growth Factors
1
2000
15
0.010
Why?
Fibroblast Growth Factor 2
1
2000
35
0.010
Why?
Lymphokines
1
2000
20
0.010
Why?
Scrotum
1
2000
31
0.010
Why?
Interleukin-1
1
2000
105
0.010
Why?
Models, Biological
1
2002
740
0.010
Why?
Breast Neoplasms
1
2004
1205
0.010
Why?
Dings's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description